The Use of Precision Dosing to Inform Personalized Medicine.
Larry Lesko (University of Florida, USA)
Model-based dosing in clinical practice.
Birgit CP Koch (Erasmus MC, The Netherlands)
The International Society of Pharmacometrics
Justin Wilkins (ISoP)
Quantitative Modeling and Simulation in PMDA: Activity and Perspective
Shinichi Kijima (Pharmaceuticals and Medical Devices Agency (PMDA))
Population pharmacokinetics of vancomycin in pediatric patients with various degrees of renal function.
Thitima Wattanavijitkul (Chulalongkorn University, Thailand)
Prediction of within-subject variability using population approaches and its application to demonstrate highly variable drug.
Hwi-yeol Yun (Chungnam National University, South Korea)
Application of Extreme Value Theory in the Analysis of Safety Data.
Peter Bonate (Astellas, USA)
The Age of Enlightenment of Model-Informed Drug Development (MIDD)
Daniele Ouellet (Pfizer, USA)
Model-Based Frameworks of CNS Biomarkers Inform Critical Early Decisions.
Mark Rogge (Takeda, USA)
Recent trends in drug development and use of pharmacometrics in China.
Peiming Ma (GlaxoSmithKline, China)
Pharmacometric modeling and simulation of osteoporosis drug: from biomarker models to fracture risk prediction
Hidefumi Kasai (Keio University, Japan)